Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Integra Lifesciences Holdings (IART) Finished Goods (2016 - 2017)

Integra Lifesciences Holdings' Finished Goods history spans 7 years, with the latest figure at $136.7 million for Q3 2017.

  • For Q3 2017, Finished Goods changed N/A year-over-year to $136.7 million; the TTM value through Sep 2017 reached $136.7 million, changed N/A, while the annual FY2016 figure was $128.0 million, N/A changed from the prior year.
  • Finished Goods for Q3 2017 was $136.7 million at Integra Lifesciences Holdings, up from $128.0 million in the prior quarter.
  • Across five years, Finished Goods topped out at $150.5 million in Q4 2014 and bottomed at $128.0 million in Q4 2016.
  • The 4-year median for Finished Goods is $141.8 million (2015), against an average of $140.5 million.